Evidence map›Paper›PMID 36986573›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

FOXO3-Activated circFGFBP1 Inhibits Extracellular Matrix Degradation and Nucleus Pulposus Cell Death via miR-9-5p/BMP2 Axis in Intervertebral Disc Degeneration In Vivo and In Vitro.

Yanlin Tan, Xiaobin Wang, Yi Zhang, Zhehao Dai, Jing Li, Chuning Dong, Xingwang Yao, Chang Lu, Fei Chen

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yanlin TanDepartment of Nuclear Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Xiaobin WangDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Yi ZhangDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Zhehao DaiDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Jing LiDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Chuning DongDepartment of Nuclear Medicine, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Xingwang YaoDepartment of Surgery Room, The Second Xiangya Hospital of Central South University, Changsha 410011, China.
Chang LuDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Fei ChenDepartment of Spine Surgery, The Second Xiangya Hospital of Central South University, No.139, Renmin Middle Road, Changsha 410011, China.
Central South University · CNSecond Xiangya Hospital of Central South University · CN

Funding

the Natural Science Foundation of Hunan Province 2021JJ30952the Natural Science Foundation of Hunan Province 2021JJ30958
6 · The paper itself

Abstract

(1) Background: intervertebral disc degeneration (IVDD) defined as the degenerative changes in intervertebral disc is characterized by extracellular matrix (ECM) degradation and death in nucleus pulposus (NP) cells. (2) Methods: The model of IVDD was established in male Sprague Dawley rats using a puncture of a 21-gauge needle at the endplates located in the L4/5 intervertebral disc. Primary NP cells were stimulated by 10 ng/mL IL-1β for 24 h to mimic IVDD impairment in vitro. (3) Results: circFGFBP1 was downregulated in the IVDD samples. circFGFBP1 upregulation inhibited apoptosis and extracellular matrix (ECM) degradation and promoted proliferation in IL-1β-stimulated NP cells. Additionally, circFGFBP1 upregulation mitigated the loss of NP tissue and the destruction of the intervertebral disc structure in vivo during IVDD. FOXO3 could bind to the circFGFBP1 promoter to enhance its expression. circFGFBP1 upregulated BMP2 expression in NP via sponging miR-9-5p. FOXO3 enhanced the protection of circFGFBP1 in IL-1β-stimulated NP cells, whereas a miR-9-5p increase partly reversed the protection. miR-9-5p downregulation contributed to the survival of IL-1β-stimulated NP cells, which was partially reversed by BMP2 silence. (4) Conclusions: FOXO3 could activate the transcription of circFGFBP1 via binding to its promoter, which resulted in the enhancement of BMP2 via sponging miR-9-5p and then inhibited apoptosis and ECM degradation in NP cells during IVDD.

Indexed as

bone morphogenetic protein 2circRNA fibroblast growth factor binding protein 1forkhead box protein O3intervertebral disc degenerationmiR-9-5p

Identifiers

PMID36986573
PMCPMC10057604
OpenAlexW4353065791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.